Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2022
8 years of board service in total across 2 boards, counting each seat separately. Longest: Addentax Group Corp., 4 years.
Addentax Group Corp.
Director
Mangoceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Addentax Group Corp. January 30, 202698.3%
-
Addentax Group Corp. June 28, 202498.9%
-
Mangoceuticals Inc. June 17, 202499.6%
-
Addentax Group Corp. March 20, 202399.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 19, 2025 | Mangoceuticals Inc. | Open-market sale | −125,000 | $1.22 | $152,500 |
| Sep 9, 2025 | Mangoceuticals Inc. | Grant or award | +100,000 | — | — |
| Sep 8, 2025 | Addentax Group Corp. | Open-market sale | −23,095 | $0.52 | $12,009 |
| Aug 11, 2025 | Addentax Group Corp. | Grant or award | +23,095 | — | — |
| Apr 10, 2025 | Mangoceuticals Inc. | Grant or award | +25,000 | — | — |
| Jun 26, 2024 | Mangoceuticals Inc. | Open-market sale | −108,426 | $0.32 | $34,696 |
| Jun 25, 2024 | Mangoceuticals Inc. | Open-market sale | −16,574 | $0.31 | $5,138 |
| Jun 3, 2024 | Mangoceuticals Inc. | Grant or award | +100,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.